BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 28222421)

  • 1. Luteolin Enhances Sarcoplasmic Reticulum Ca2+-ATPase Activity through p38 MAPK Signaling thus Improving Rat Cardiac Function after Ischemia/Reperfusion.
    Zhu S; Xu T; Luo Y; Zhang Y; Xuan H; Ma Y; Pan D; Li D; Zhu H
    Cell Physiol Biochem; 2017; 41(3):999-1010. PubMed ID: 28222421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidative effect of luteolin pretreatment on simulated ischemia/reperfusion injury in cardiomyocyte and perfused rat heart.
    Zhang RQ; Li DY; Xu TD; Zhu SS; Pan HJ; Fang F; Wu X; Sun H
    Chin J Integr Med; 2017 Jul; 23(7):518-527. PubMed ID: 26956461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Luteolin Modulates SERCA2a Leading to Attenuation of Myocardial Ischemia/ Reperfusion Injury via Sumoylation at Lysine 585 in Mice.
    Du Y; Liu P; Xu T; Pan D; Zhu H; Zhai N; Zhang Y; Li D
    Cell Physiol Biochem; 2018; 45(3):883-898. PubMed ID: 29421780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERK/PP1a/PLB/SERCA2a and JNK pathways are involved in luteolin-mediated protection of rat hearts and cardiomyocytes following ischemia/reperfusion.
    Wu X; Xu T; Li D; Zhu S; Chen Q; Hu W; Pan D; Zhu H; Sun H
    PLoS One; 2013; 8(12):e82957. PubMed ID: 24386130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luteolin inhibits apoptosis and improves cardiomyocyte contractile function through the PI3K/Akt pathway in simulated ischemia/reperfusion.
    Fang F; Li D; Pan H; Chen D; Qi L; Zhang R; Sun H
    Pharmacology; 2011; 88(3-4):149-58. PubMed ID: 21934351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Luteolin inhibits ROS-activated MAPK pathway in myocardial ischemia/reperfusion injury.
    Yu D; Li M; Tian Y; Liu J; Shang J
    Life Sci; 2015 Feb; 122():15-25. PubMed ID: 25476833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin regulates SR Ca(2+) cycling following ischemia/reperfusion via sphingosine 1-phosphate-CaMKII signaling in mice.
    Yan W; Zhang F; Zhang R; Zhang X; Wang Y; Zhou F; Xia Y; Liu P; Gao C; Wang H; Zhang L; Zhou J; Gao F; Gao E; Koch WJ; Wang H; Cheng H; Qu Y; Tao L
    J Mol Cell Cardiol; 2014 Sep; 74():183-92. PubMed ID: 24852843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin inhibits beta-adrenergic action in ischemic/reperfused heart: a novel mechanism of insulin in cardioprotection.
    Yu QJ; Si R; Zhou N; Zhang HF; Guo WY; Wang HC; Gao F
    Apoptosis; 2008 Feb; 13(2):305-17. PubMed ID: 18165901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ROS generated during early reperfusion contribute to intermittent hypobaric hypoxia-afforded cardioprotection against postischemia-induced Ca(2+) overload and contractile dysfunction via the JAK2/STAT3 pathway.
    Wu L; Tan JL; Wang ZH; Chen YX; Gao L; Liu JL; Shi YH; Endoh M; Yang HT
    J Mol Cell Cardiol; 2015 Apr; 81():150-61. PubMed ID: 25731682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Luteolin modulates SERCA2a via Sp1 upregulation to attenuate myocardial ischemia/reperfusion injury in mice.
    Hu Y; Zhang C; Zhu H; Wang S; Zhou Y; Zhao J; Xia Y; Li D
    Sci Rep; 2020 Sep; 10(1):15407. PubMed ID: 32958799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taxol, a microtubule stabilizer, improves cardiac functional recovery during postischemic reperfusion in rat in vitro.
    Xiao J; Liang D; Liu Y; Zhang H; Liu Y; Zhao H; Li J; Peng L; Zhou Z; Chen YH
    Cardiovasc Ther; 2012 Feb; 30(1):12-30. PubMed ID: 20553295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischemic postconditioning protects the heart against ischemia-reperfusion injury via neuronal nitric oxide synthase in the sarcoplasmic reticulum and mitochondria.
    Hu L; Wang J; Zhu H; Wu X; Zhou L; Song Y; Zhu S; Hao M; Liu C; Fan Y; Wang Y; Li Q
    Cell Death Dis; 2016 May; 7(5):e2222. PubMed ID: 27171264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luteolin Inhibits Ischemia/Reperfusion-Induced Myocardial Injury in Rats via Downregulation of microRNA-208b-3p.
    Bian C; Xu T; Zhu H; Pan D; Liu Y; Luo Y; Wu P; Li D
    PLoS One; 2015; 10(12):e0144877. PubMed ID: 26658785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p38α regulates SERCA2a function.
    Kaikkonen L; Magga J; Ronkainen VP; Koivisto E; Perjes Á; Chuprun JK; Vinge LE; Kilpiö T; Aro J; Ulvila J; Alakoski T; Bibb JA; Szokodi I; Koch WJ; Ruskoaho H; Kerkelä R
    J Mol Cell Cardiol; 2014 Feb; 67():86-93. PubMed ID: 24361238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin improves cardiomyocyte contractile function through enhancement of SERCA2a activity in simulated ischemia/reperfusion.
    Yu J; Zhang HF; Wu F; Li QX; Ma H; Guo WY; Wang HC; Gao F
    Acta Pharmacol Sin; 2006 Jul; 27(7):919-26. PubMed ID: 16787577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The YAP/SERCA2a signaling pathway protects cardiomyocytes against reperfusion-induced apoptosis.
    Zhong J; Ouyang H; Zheng S; Guo Z; Chen Y; Zhong Y; Zhong W; Zuo L; Lu J
    Aging (Albany NY); 2020 Jul; 12(13):13618-13632. PubMed ID: 32645692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of Protein Kinase Novel 1 (PKN1) is associated with mild systolic and diastolic contractile dysfunction, increased phospholamban Thr17 phosphorylation, and exacerbated ischaemia-reperfusion injury.
    Francois AA; Obasanjo-Blackshire K; Clark JE; Boguslavskyi A; Holt MR; Parker PJ; Marber MS; Heads RJ
    Cardiovasc Res; 2018 Jan; 114(1):138-157. PubMed ID: 29045568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HNO enhances SERCA2a activity and cardiomyocyte function by promoting redox-dependent phospholamban oligomerization.
    Sivakumaran V; Stanley BA; Tocchetti CG; Ballin JD; Caceres V; Zhou L; Keceli G; Rainer PP; Lee DI; Huke S; Ziolo MT; Kranias EG; Toscano JP; Wilson GM; O'Rourke B; Kass DA; Mahaney JE; Paolocci N
    Antioxid Redox Signal; 2013 Oct; 19(11):1185-97. PubMed ID: 23919584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of p38 MAPK activation protects cardiac mitochondria from ischemia/reperfusion injury.
    Kumphune S; Surinkaew S; Chattipakorn SC; Chattipakorn N
    Pharm Biol; 2015; 53(12):1831-41. PubMed ID: 25880145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CaMKII-dependent phosphorylation of cardiac ryanodine receptors regulates cell death in cardiac ischemia/reperfusion injury.
    Di Carlo MN; Said M; Ling H; Valverde CA; De Giusti VC; Sommese L; Palomeque J; Aiello EA; Skapura DG; Rinaldi G; Respress JL; Brown JH; Wehrens XH; Salas MA; Mattiazzi A
    J Mol Cell Cardiol; 2014 Sep; 74():274-83. PubMed ID: 24949568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.